Literature DB >> 33670400

Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.

Juliane Strietz1,2, Stella S Stepputtis2, Marie Follo3, Peter Bronsert4, Elmar Stickeler5, Jochen Maurer2,5.   

Abstract

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, with only limited treatment options available. Recently, cancer stem cells (CSCs) have emerged as the potential drivers of tumor progression due to their ability to both self-renew and give rise to differentiated progeny. The CSC state has been linked to the process of epithelial-mesenchymal transition (EMT) and to the highly flexible state of epithelial-mesenchymal plasticity (EMP). We aimed to establish primary breast cancer stem cell (BCSC) cultures isolated from TNBC specimens. These cells grow as tumor spheres under anchorage-independent culture conditions in vitro and reliably form tumors in mice when transplanted in limiting dilutions in vivo. The BCSC xenograft tumors phenocopy the original patient tumor in architecture and gene expression. Analysis of an EMT-related marker profile revealed the concomitant expression of epithelial and mesenchymal markers suggesting an EMP state for BCSCs of TNBC. Furthermore, BCSCs were susceptible to stimulation with the EMT inducer TGF-β1, resulting in upregulation of mesenchymal genes and enhanced migratory abilities. Overall, primary BCSC cultures are a promising model close to the patient that can be used both in vitro and in vivo to address questions of BCSC biology and evaluate new treatment options for TNBC.

Entities:  

Keywords:  cancer stem cells; epithelial-mesenchymal plasticity; epithelial-mesenchymal transition; triple-negative breast cancer

Mesh:

Substances:

Year:  2021        PMID: 33670400      PMCID: PMC7918351          DOI: 10.3390/ijms22041808

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  67 in total

1.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

Review 2.  The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Authors:  Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

3.  Clinical implications of stem cell gene Oct-4 expression in breast cancer.

Authors:  Cai-gang Liu; Ying Lu; Bin-bin Wang; Yan-jun Zhang; Rui-shan Zhang; Yang Lu; Bo Chen; Huimian Xu; Feng Jin; Ping Lu
Journal:  Ann Surg       Date:  2011-06       Impact factor: 12.969

4.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

5.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 6.  Relevance of breast cancer cell lines as models for breast tumours: an update.

Authors:  Marc Lacroix; Guy Leclercq
Journal:  Breast Cancer Res Treat       Date:  2004-02       Impact factor: 4.872

7.  Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

Authors:  Socorro M Rodriguez-Pinilla; David Sarrio; Gema Moreno-Bueno; Yolanda Rodriguez-Gil; Miguel A Martinez; Lucia Hernandez; David Hardisson; Jorge S Reis-Filho; Jose Palacios
Journal:  Mod Pathol       Date:  2007-03-02       Impact factor: 7.842

Review 8.  Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.

Authors:  Appalaraju Jaggupilli; Eyad Elkord
Journal:  Clin Dev Immunol       Date:  2012-05-30

9.  DIE-RNA: A Reproducible Strategy for the Digestion of Normal and Injured Pancreas, Isolation of Pancreatic Cells from Genetically Engineered Mouse Models and Extraction of High Quality RNA.

Authors:  Mohamad Assi; Nicolas Dauguet; Patrick Jacquemin
Journal:  Front Physiol       Date:  2018-02-27       Impact factor: 4.566

10.  Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.

Authors:  Mingshan Liu; Yang Liu; Lu Deng; Dong Wang; Xueyan He; Lei Zhou; Max S Wicha; Fan Bai; Suling Liu
Journal:  Mol Cancer       Date:  2018-02-23       Impact factor: 27.401

View more
  4 in total

Review 1.  Tumour Stem Cells in Breast Cancer.

Authors:  Marina Ibragimova; Matvey Tsyganov; Nikolai Litviakov
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

Review 2.  Signaling pathways governing breast cancer stem cells behavior.

Authors:  Kai Song; Maryam Farzaneh
Journal:  Stem Cell Res Ther       Date:  2021-04-16       Impact factor: 6.832

Review 3.  (Im)maturity in Tumor Ecosystem.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 4.  The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.

Authors:  Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.